Learn more about our active infectious disease clinical trials. All relevant information for individual trials can be found on each study listed here. All trials are conducted by our clinical research team including specialists in infectious disease.
Pinnacle Research Group was established in 1998 and is at the cutting edge of clinical trials in the USA. We conduct phase I-IV clinical drug and device studies over a broad therapeutic area, with particular interest in early phase development projects. We have enrolled thousands of participants in hundreds of studies. Our expert research team has experience in studies across the research spectrum, from first-in-human and early phase protocols, to late phase pivotal studies. Our highly trained staff and decades of experience make us a valued resource for participants, physicians, and our pharmaceutical industry partners. Our participants decide to join a clinical trial for a range of reasons including:
Gain access to new medicines and cutting-edge therapies
Benefit from a thorough review of your medical history and expert care throughout the study
Advance medical science for those living with chronic illnesses. An opportunity to participate in something bigger than ourselves.
Since opening our doors in 1998 our highly qualified research team has participated in over 500 studies and has provided results obtained at the highest level of expertise, safety, and ethics. Clinical trials are conducted in our state-of-the-art, Phase I to IV facility in Anniston, Alabama. Our facility can host in-patient and outpatient studies and includes a 7,300ft² phase one unit with 16 beds. We have solid relationships with pharmaceutical companies, with our patients, with our local community, and with medical professionals. Get in touch to see how we can advance your treatment solutions.About Pinnacle